Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Metastatic Prostate Cancer”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Large-scale testing (Phase 3)Study completedNCT02294461
What this trial is testing

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Who this might be right for
Progressive Metastatic Prostate Cancer
Astellas Pharma Inc 395
Early research (Phase 1)Study completedNCT01692262
What this trial is testing

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,+3 more
AstraZeneca 59
Testing effectiveness (Phase 2)Ended earlyNCT00479635
What this trial is testing

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Cortice Biosciences, Inc. 26
Not applicableStudy completedNCT06460454
What this trial is testing

PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

Who this might be right for
Prostate Cancer
Central Hospital, Nancy, France 100
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01688492
What this trial is testing

Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 54
Post-approval studies (Phase 4)Active Not RecruitingNCT04597125
What this trial is testing

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Bayer 654
Testing effectiveness (Phase 2)UnknownNCT00987675
What this trial is testing

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 26
Not applicableActive Not RecruitingNCT04030338
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Who this might be right for
Prostate CancerProstate NeoplasmProstate Adenocarcinoma+2 more
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Not applicableStudy completedNCT04281147
What this trial is testing

Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Who this might be right for
Prostate Cancer
Bayer 4,301
Early research (Phase 1)Ended earlyNCT04033328
What this trial is testing

Study of ORIC-101 in Combination With Enzalutamide

Who this might be right for
Prostatic Neoplasms
ORIC Pharmaceuticals 41
Not applicableStudy completedNCT00578409
What this trial is testing

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 758
Testing effectiveness (Phase 2)Active Not RecruitingNCT03725761
What this trial is testing

Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 31
Testing effectiveness (Phase 2)Study completedNCT00330161
What this trial is testing

Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT07206056
What this trial is testing

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Who this might be right for
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals 188
Testing effectiveness (Phase 2)Ended earlyNCT01253642
What this trial is testing

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostatic AdenocarcinomaProstate Adenocarcinoma+1 more
OHSU Knight Cancer Institute 11
Early research (Phase 1)Ended earlyNCT05124795
What this trial is testing

IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Immunic AG 18
Testing effectiveness (Phase 2)Study completedNCT03392428
What this trial is testing

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateMetastatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 201
Testing effectiveness (Phase 2)Study completedNCT03418324
What this trial is testing

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 11
Load More Results